Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Section Details


ORIGINAL ARTICLES

 
Issue Title
 
Vol 13, No 3 (2020) Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making Abstract   PDF (Rus)
V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy
 
Vol 13, No 3 (2020) Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs Abstract   PDF (Rus)
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov
 
Vol 13, No 3 (2020) The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation Abstract   PDF (Rus)
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova
 
Vol 13, No 3 (2020) Parameters for evaluating the main indicators of coloproctological care in the adult population in the subjects of the far Eastern Federal District in 2016–2018 Abstract   PDF (Rus)
A. V. Veselov, V. V. Omelyanosvkiy, Yu. A. Shelygin, A. V. Vitko, V. N. Kashnikov, N. V. Tashkinov, T. V. Shkurko, A. I. Moskalev, A. A. Serbina
 
Vol 13, No 3 (2020) Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up Abstract   PDF (Rus)
L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko
 
Vol 13, No 3 (2020) The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups Abstract   PDF (Rus)
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
 
Vol 13, No 2 (2020) Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation Abstract   PDF (Rus)
S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva
 
Vol 13, No 2 (2020) COVID-19 pandemic: protective role of vitamin D Abstract   PDF (Rus)
O. A. Gromova, I. Yu. Torshin, G. Kh. Gabdulina
 
Vol 13, No 2 (2020) Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news Abstract   PDF (Rus)
I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, N. P. Vanchakova, A. N. Galustyan, Zh. D. Kobalava, T. R. Grishina, A. N. Gromov, I. A. Ilovaiskaya, V. M. Kodentsova, A. G. Kalacheva, O. A. Limanova, V. A. Maksimov, S. I. Malyavskaya, E. V. Mozgovaya, N. I. Tapilskaya, K. V. Rudakov, V. A. Semenov
 
Vol 13, No 2 (2020) Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome Abstract   PDF (Rus)
M. A. Chernyavskaya, I. A. Narkevich
 
Vol 13, No 2 (2020) Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation Abstract   PDF (Rus)
S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova
 
Vol 13, No 2 (2020) Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 Abstract   PDF (Rus)
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
 
Vol 12, No 4 (2019) Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis Abstract   PDF (Rus)
I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation Abstract   PDF (Rus)
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer Abstract   PDF (Rus)
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract   PDF (Rus)
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
 
Vol 12, No 4 (2019) Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation Abstract   PDF (Rus)
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev
 
Vol 12, No 4 (2019) Crucial areas of the economic analysis of public cancer care Abstract   PDF (Rus)
D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova
 
Vol 12, No 2 (2019) Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers Abstract   PDF (Rus)
E. V. Radchenko, A. S. Kolbin
 
Vol 12, No 2 (2019) Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria Abstract   PDF (Rus)
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova
 
Vol 12, No 2 (2019) Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU Abstract   PDF (Rus)
G. N. Gildeeva, A. V. Belostotsky
 
1 - 21 of 21 Items